Treatment of Neuroendocrine Tumors with LU 177 Dotatate

Recorded On: 11/02/2019

  • Register
    • Non-member - $40
    • Member - $30
    • Resident/Fellow - $10
    • Student - $10

The speaker will detail the main indication for Lutetium-177 dotatate treatment, how to screen and select the appropriate patient for referral, and the main benefits and risks of the treatment.  This lecture was recorded on November 02, 2019 at the 2019 ACOI Annual Convention and Scientific Sessions held in Phoenix, AZ.

Mark Tulchinsky, MD

Professor of Radiology and Medicine

Professor of Radiology and Medicine
Associate Chief, Division of Nuclear Medicine
The Pennsylvania State University College of Medicine
PennState Milton S. Hershey Medical Center
Hershey, PA

Components visible upon registration.